271: Racing for gene therapy, a pioneering approval, & startups in the lurch episode artwork

EPISODE · Aug 18, 2023 · 34 MIN

271: Racing for gene therapy, a pioneering approval, & startups in the lurch

from The Readout Loud · host STAT

Our colleague Jason Mast joins us to explain how the approval of a landmark gene therapy for Duchenne muscular dystrophy set in motion a frantic race to get children treated before their 6th birthdays. Then, HSBC Managing Director Jonathan Norris calls in to discuss why so many biotech startups are facing financial bridges to nowhere.

Episode metadata supplied by the publisher feed · Published Aug 18, 2023

Embed this episode

NOW PLAYING

271: Racing for gene therapy, a pioneering approval, & startups in the lurch

0:00 34:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 34 minutes long.

When was this The Readout Loud episode published?

This episode was published on August 18, 2023.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!